SCOPUS 정보 검색 플랫폼

Volumn 65, Issue 2, 2001, Pages 125-134

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-Year results from the MORE trial

(19) Cauley, J A a Norton, L b Lippman, M E c Eckert, S d Krueger, K A e Purdie, D W e Farrerons, J f Karasik, A g Mellstrom, D h Ng, K W i Stepan, J J j Powles, T J k Morrow, M l Costa, A m Silfen, S L e Walls, E L e Schmitt, H e Muchmore, D B d Jordan, V C l

a UNIVERSITY OF PITTSBURGH (United States)

b MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

c GEORGETOWN UNIVERSITY (United States)

d Applied Logic Associates Inc (United States)

e UNIVERSITY OF HULL (United Kingdom)

f Hospital Santa Cruz and San Pablo (Spain)

g SHEBA MEDICAL CENTER (Israel)

h SAHLGRENSKA UNIVERSITY HOSPITAL (Sweden)

i UNIVERSITY OF MELBOURNE (Australia)

more..

Author keywords

Breast cancer; Menopause; MORE trial; Osteoporosis; Raloxifene; SERM; STAR trial; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HOT FLUSH; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0035120523 PISSN: 01676806 EISSN: None Source Type: Journal
DOI: 10.1023/A:1006478317173 Document Type: Article

Times cited : (673)

References (29)

1
- 0032537990
- Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
- (1998) J Natl Cancer Inst , vol.90 , pp. 1371-1388
- Fisher, B.¹ Costantino, J.P.² Wickerham, D.L.³ Redmond, C.K.⁴ Kavanah, M.⁵ Cronin, W.M.⁶ Vogel, V.⁷ Robidoux, A.⁸ Dimitrov, N.⁹ Atkins, J.¹⁰ Daly, M.¹¹ Wieand, S.¹² Tan-Chiu, E.¹³ Ford, L.¹⁴ Wolmark, N.¹⁵

2
- 0031619604
- Tamoxifen and the endometrium
- (1998) Cancer Treat Res , vol.94 , pp. 195-207
- Barakat, R.R.¹

3
- 0033989737
- Uterine effects of three-year raloxifene therapy in in postmenopausal women under age 60
- (2000) Obstet Gynecol , vol.95 , pp. 104-110
- Cohen, F.J.¹ Watts, S.² Shah, A.³ Akers, R.⁴ Plouffe, L.⁵

4
- 0033575083
- The effect of raloxifene on risk of breast cancer in postmenopausal women
- (1999) JAMA , vol.281 , pp. 2189-2197
- Cummings, S.¹ Eckert, S.² Krueger, K.³ Grady, D.⁴ Powles, T.⁵ Cauley, J.⁶ Norton, L.⁷ Nickelsen, T.⁸ Bjarnason, N.⁹ Morrow, M.¹⁰ Lippman, M.¹¹ Black, D.¹² Glusman, J.¹³ Costa, A.¹⁴ Jordan, V.C.¹⁵

5
- 0004032645
- Press Release of National Cancer Institute
- (1999) Publication of the MORE Trial Results Support Study of Tamoxifen and Raloxifene (STAR)

6
- 0030664688
- Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
- (1997) N Engl J Med , vol.337 , pp. 1641-1647
- Delmas, P.D.¹ Bjarnason, N.H.² Mitlak, B.H.³ Ravoux, A.-C.⁴ Shah, A.S.⁵ Huster, W.J.⁶ Draper, M.⁷ Christiansen, C.⁸

7
- 0033581212
- Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
- (1999) JAMA , vol.282 , pp. 637-645
- Ettinger, B.¹ Black, D.M.² Mitlak, B.H.³ Knickerbocker, R.K.⁴ Nickelsen, T.⁵ Genant, H.K.⁶ Christiansen, C.⁷ Delmas, P.D.⁸ Zanchetta, J.R.⁹ Stakkestad, J.¹⁰ Gluer, C.C.¹¹ Krueger, K.¹² Cohen, F.J.¹³ Eckert, S.¹⁴ Ensrud, K.¹⁵ Avioli, L.V.¹⁶ Lips, P.¹⁷ Cummings, S.R.¹⁸

8
- 2642712522
- Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
- (1998) JAMA , vol.279 , pp. 1445-1451
- Walsh, B.W.¹ Kuller, L.H.² Wild, R.A.³ Paul, S.⁴ Farmer, M.⁵ Lawrence, J.B.⁶ Shah, A.S.⁷ Anderson, P.W.⁸

9
- 0031708649
- Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene
- (1998) J Womens Health , vol.7 , pp. 839-847
- Barrett-Connor, E.¹ Wenger, N.K.² Grady, D.³ Mosca, L.⁴ Collins, P.⁵ Kornitzer, M.⁶ Cox, D.A.⁷ Moscarelli, E.⁸ Anderson, P.W.⁹

10
- 0032508293
- Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study
- (1998) Lancet , vol.352 , pp. 93-97
- Veronesi, U.¹ Maisonneuve, P.² Costa, A.³ Sacchini, V.⁴ Maltoni, C.⁵ Robertson, C.⁶ Rotmensz, N.⁷ Boyle, P.⁸

11
- 0032508294
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
- (1998) Lancet , vol.352 , pp. 98-101
- Powles, T.¹ Eeles, R.² Ashley, S.³ Easton, D.⁴ Chang, J.⁵ Dowsett, M.⁶ Tidy, A.⁷ Viggers, J.⁸ Davey, J.⁹

12
- 0345567604
- Molecular determinants of tissue selectivity in estrogen receptor modulators
- (1997) Proceedings of the Natl Acad Sci USA , vol.94 , pp. 14105-14110
- Grese, T.A.¹ Sluka, J.P.² Bryant, H.U.³ Cullinan, G.J.⁴ Glasebrook, A.L.⁵ Jones, C.D.⁶ Matsumoto, K.⁷ Palkowitz, A.D.⁸ Sato, M.⁹ Termine, J.D.¹⁰ Winter, M.A.¹¹ Yang, N.N.¹² Dodge, J.A.¹³

13
- 0030667676
- Molecular basis of agonism and antagonism in the oestrogen receptor
- (1997) Nature , vol.389 , pp. 753-758
- Brzozowski, A.M.¹ Pike, A.C.W.² Dauter, Z.³ Hubbard, R.E.⁴ Bonn, T.⁵ Engstrom, O.⁶ Ohman, L.⁷ Greene, G.L.⁸ Gustafsson, J.-A.⁹ Carlquist, M.¹⁰

14
- 0033013227
- Adverse events reporters by post menopausal women in controlled trials with raloxifene
- (1999) Obstet Gynecol , vol.93 , pp. 558-565
- Davies, G.¹ Huster, W.J.² Lu, Y.³ Plouffe, L.⁴ Lakshmanan, M.⁵

15
- 0033574030
- Effects of estrogen and estrogen-progestin on mammographic parenchymal density
- (1999) Ann Intern Med , vol.130 , pp. 262-269
- Greendale, G.A.¹ Reboussin, B.A.² Sie, A.³ Singh, H.R.⁴ Olson, L.K.⁵ Gatewood, O.⁶ Bassett, L.W.⁷ Wasilauskas, C.⁸ Bush, T.⁹ Barrett-Connor, E.¹⁰

16
- 0034700867
- Hormone replacement therapy and accuracy of mammographic screening
- (2000) Lancet , vol.355 , pp. 270-274
- Kavanagh, A.M.¹ Mitchell, H.² Giles, G.G.³

17
- 0035798776
- Digitized mammography: A clinical trial of post menopausal women randomized to raloxifene, estrogen, or placebo
- In press
- J Natl Cancer Inst
- Freedman, M.¹ San Martin, J.² O'Gorman, J.³ Eckert, S.⁴ Lippman, M.E.⁵ Lo, S.-C.⁶ Walls, E.L.⁷ Zeng, J.⁸

18
- 0029858793
- Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group
- (1996) JAMA , vol.276 , pp. 1404-1408
- Cauley, J.A.¹ Lucas, F.L.² Kuller, L.H.³ Vogt, M.T.⁴ Browner, W.S.⁵ Cummings, S.R.⁶

19
- 0031049425
- Bone mass and the risk of breast cancer among postmenopausal women
- (1997) N Engl J Med , vol.336 , pp. 611-617
- Zhang, Y.¹ Kiel, D.P.² Kreger, B.E.³ Cupples, L.A.⁴ Ellison, R.C.⁵ Dorgan, J.F.⁶ Schatzkin, A.⁷ Levy, D.⁸ Felson, D.T.⁹

20
- 0033573946
- Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group
- (1999) Ann Intern Med , vol.130 , pp. 270-277
- Cauley, J.A.¹ Lucas, F.L.² Kuller, L.H.³ Stone, K.⁴ Browner, W.⁵ Cummings, S.R.⁶

21
- 0003405565
- National Cancer Institute, Bethesda
- (1999) SEER Cancer Statistics Review, 1973-1996
- Ries, L.A.G.¹ Kosary, C.L.² Hankey, B.F.³ Miller, B.A.⁴ Clegg, L.⁵ Edwards, B.K.⁶

22
- 0034650419
- Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials
- (2000) Maturitas , vol.34 , pp. 65-73
- Cohen, F.J.¹ Lu, Y.²

23
- 0028793801
- Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients
- (1995) Gynecol Oncol , vol.59 , pp. 261-266
- Tomas, E.¹ Kauppila, A.² Blanco, G.³ Apaja-Sarkkinen, M.⁴ Laatikainen, T.⁵

24
- 0030217941
- Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
- (1996) Maturitas , vol.25 , pp. 45-50
- Dijkhuizen, F.P.H.L.J.¹ Brolmann, H.A.M.² Oddens, B.J.J.³ Roumen, R.M.H.⁴ Coebergh, J.W.W.⁵ Heintz, A.P.M.⁶

25
- 0013667147
- (1998) Nolvadex (tamoxifen citrate) Package Insert

26
- 0031857831
- Factors influencing the presence of uterine cavity fluid in a random sample of asymptomatic postmenopausal women
- (1998) Acta Obstet Gynecol Scand , vol.77 , pp. 751-757
- Gull, B.¹ Karlsson, B.² Wikland, M.³ Milsom, I.⁴ Granberg, S.⁵

27
- 0030183597
- Endometrial fluid accumulation in asymptomatic postmenopausal women
- (1996) Ultrasound in Obstet Gynecol , vol.8 , pp. 37-41
- Vuento, M.H.¹ Pirhonen, J.P.² Makinen, J.I.³ Tyrkko, J.E.⁴ Laippala, P.J.⁵ Gronroos, M.⁶ Salmi, T.A.⁷

28
- 0028238321
- Postmenopausal endometrial fluid collections revisited: Look at the doughnut rather than the hole
- (1994) Obstet Gynecol , vol.83 , pp. 738-740
- Goldstein, S.R.¹

29
- 0032547326
- Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
- (1998) JAMA , vol.280 , pp. 605-613
- Hulley, S.¹ Grady, D.² Bush, T.³ Furberg, C.⁴ Herrington, D.⁵ Riggs, B.⁶ Vittinghoff, E.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.